IRIS
CAPRANZANO, PIERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.495
AS - Asia 4.251
EU - Europa 2.832
SA - Sud America 678
AF - Africa 436
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 16.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.214
SG - Singapore 2.341
CN - Cina 1.278
IE - Irlanda 859
UA - Ucraina 593
BR - Brasile 585
IT - Italia 447
RU - Federazione Russa 408
CI - Costa d'Avorio 330
VN - Vietnam 298
CA - Canada 241
SE - Svezia 128
KR - Corea 99
GB - Regno Unito 79
FR - Francia 65
DE - Germania 63
IN - India 62
SN - Senegal 43
NL - Olanda 37
AR - Argentina 34
BD - Bangladesh 31
MX - Messico 25
UZ - Uzbekistan 24
ZA - Sudafrica 24
AT - Austria 23
IQ - Iraq 22
PL - Polonia 22
ES - Italia 21
BE - Belgio 19
CH - Svizzera 18
EC - Ecuador 18
FI - Finlandia 17
HK - Hong Kong 14
ID - Indonesia 13
GR - Grecia 12
BJ - Benin 10
IR - Iran 10
TR - Turchia 10
VE - Venezuela 10
JP - Giappone 9
MA - Marocco 9
PK - Pakistan 8
UY - Uruguay 8
PE - Perù 7
CO - Colombia 5
EU - Europa 5
KE - Kenya 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
NG - Nigeria 4
NP - Nepal 4
RS - Serbia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
JO - Giordania 3
OM - Oman 3
AL - Albania 2
AU - Australia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
LB - Libano 2
LT - Lituania 2
SA - Arabia Saudita 2
TV - Tuvalu 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.703
Salva come PNG Salva come JPEG
Città #
Dallas 1.440
Singapore 1.200
Santa Clara 1.130
Dublin 859
Jacksonville 803
Chandler 684
Houston 500
Boardman 401
Abidjan 330
Ashburn 295
Nanjing 245
Hefei 241
Chicago 238
Andover 214
Cambridge 213
Lawrence 213
Toronto 171
Catania 141
Des Moines 141
Beijing 133
Dong Ket 125
Moscow 120
Los Angeles 117
Civitanova Marche 105
Seoul 99
Nanchang 83
Wilmington 83
San Mateo 76
Hebei 63
Ho Chi Minh City 59
São Paulo 53
Shenyang 52
Ottawa 48
Hanoi 47
Jiaxing 47
Saint Petersburg 45
Dakar 43
Council Bluffs 41
Tianjin 39
Buffalo 38
Changsha 38
The Dalles 37
Columbus 34
Bremen 31
Washington 31
New York 30
Amsterdam 22
Rio de Janeiro 22
Brooklyn 21
Norwalk 21
Pune 21
Seattle 21
Phoenix 20
Brussels 19
Kunming 17
Ningbo 17
Falls Church 16
Hangzhou 16
Belo Horizonte 15
San Francisco 15
Helsinki 14
Jinan 14
London 14
Milan 14
Redondo Beach 14
Boston 13
Hong Kong 13
Guangzhou 12
Johannesburg 12
Stockholm 12
Atlanta 11
Den Haag 11
Warsaw 11
Cotonou 10
Denver 10
Baghdad 9
Haiphong 9
Santos 9
Tokyo 9
Zhengzhou 9
Chennai 8
Curitiba 8
Da Nang 8
Dhaka 8
Guayaquil 8
Liberty Lake 8
Montreal 8
Mumbai 8
Porto Alegre 8
Tehran 8
Ann Arbor 7
Brasília 7
Charlotte 7
Edinburgh 7
Montevideo 7
Nuremberg 7
Palermo 7
Santo André 7
Elk Grove Village 6
Guarulhos 6
Totale 11.817
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 531
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 177
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 150
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry 139
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 124
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 120
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 114
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 112
Early cardiovascular remodelling in Fabry disease 112
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 107
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 106
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 105
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 105
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 105
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 104
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 104
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 103
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 101
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 101
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry 100
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 99
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey 96
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 95
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 95
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 93
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 93
Appraisal of key trials in aortic and mitral fields 92
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 91
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 91
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 91
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 91
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 90
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 90
Clinical implication of different plaque distribution patterns in distal left main coronary artery 90
Retrograde Approach for Chronic Total Occlusion Percutaneous Coronary Intervention: The Paradox of Choice 89
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 89
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 89
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 88
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study 88
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 87
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 86
A Novel Mechanism by Which MitraClip Implantation May Favorably Alter the Natural History of Left Ventricular Remodeling in Patients with Mitral Regurgitation: Proposed Role of the Ventricular-Valvular Loop 86
Antiplatelet drug response variability and the role of platelet function testing: A practical guide for interventional cardiologists 86
Transcatheter Aortic-Valve Replacement 85
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 85
Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems 84
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 84
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 84
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 83
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 82
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 82
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 81
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 81
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 81
Update on clinical evidence (Part II): a summary of the main post market studies 80
Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting Stent (TEST) registry 79
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 79
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 78
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patients. 78
Parenteral Anticoagulant Agents in PCI 77
Risk stratification for secondary prevention with ticagrelor and aspirin: a closer look to patient subsets from the PEGASUS-TIMI 54 trial 76
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 76
Risk stratification after ST-elevation myocardial infarction 76
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 76
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease 76
Impact of Residual Platelet Reactivity on reperfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention 76
MitraClip Implantation for the Treatment of New-Onset Systolic Anterior Motion of the Mitral Valve After Transcatheter Aortic Valve Replacement 76
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 75
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry) 75
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 75
Serum cotinine levels are associated with increased clopidogrel-induced antiplatelet effects 75
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry 75
One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? 74
Simultaneous plaque rupture and erosion in the same atheroma: insights from two and three-dimensional optical coherence tomography 74
Capitolo 2 - Diagnostica cardiovascolare 74
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist. A review on its mechanism of action and clinical development 74
Revascularization vs. Optimal Medical Therapy in Women with NSTE-ACS 74
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis 73
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry 73
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 73
CABG Versus PCI In Diabetic Patients With Multivessel Disease After Risk Stratification By The SYNTAX Score: A Pooled Analysis Of The SYNTAX And FREEDOM Trials 73
Self-apposing STENTYS stent in acute myocardial infarction 73
Clinical development of selective anticoagulants: a state of the art 72
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy 72
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients 72
PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE 72
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 72
Antithrombotic Management of Elderly Patients With Coronary Artery Disease 71
How true delivery profile diminution reduces vascular access challenges and complications 71
L'angioplastica complessa al posto del by-pass: ruolo degli score di rischio 71
Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 71
Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE registry) 71
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation 71
Impact of direct oral anticoagulants on evolution of post-thrombotic syndrome 70
Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. 70
Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry 70
Motivations for and barriers to choosing an interventional cardiology career path: Results from the EAPCI Women Committee worldwide survey 70
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. 70
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry 69
Gestione della terapia antitrombotica nei pazienti con sanguinamento dopo angioplastica coronarica [Management of antithrombotic therapy in patients with bleeding after percutaneous coronary intervention] 68
Totale 9.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021626 0 0 0 0 0 27 166 4 88 2 181 158
2021/20221.478 169 231 2 24 256 15 223 55 116 1 20 366
2022/20232.435 219 51 19 192 333 437 7 380 679 10 75 33
2023/20241.207 63 216 60 87 51 268 31 50 3 29 199 150
2024/20254.141 32 584 281 173 1.041 412 62 147 381 434 250 344
2025/20264.426 512 442 1.575 422 1.452 23 0 0 0 0 0 0
Totale 17.094